Skip to main content

NIDDK Archives

Targeting diabetic kidney disease

Oct. 16, 2018—Raymond Harris, Ming-Zhi Zhang and colleagues suggest pathways activated by the epidermal growth factor receptor may be promising targets for treating diabetic kidney disease.

Read more


Insulin accelerant

Oct. 16, 2018—Reducing nitric oxide helps insulin move more quickly through blood vessels, find David Wasserman and colleagues.

Read more


Mass spectrometry team earns grant to map body at the cellular level

Sep. 28, 2018—Biochemistry professor Richard Caprioli, director of the Mass Spectrometry Research Center, and Jeff Spraggins, research assistant professor of biochemistry, and their team will build a platform to molecularly characterize cells.

Read more


Diabetes drug may prevent liver cancer

Sep. 21, 2018—A new study by Harvey Murff finds that diabetics who take metformin have lower rates of liver cancer than those who take other diabetes drugs.

Read more


Investigators find that bile acids reduce cocaine reward

Aug. 30, 2018—The discovery that high levels of bile acids appear to blunt cravings for cocaine could lead to new treatments for addiction.

Read more


Toxin floats on lipid rafts

Apr. 23, 2018—The bacterium H. pylori is a leading cause of stomach cancer, and Vanderbilt researchers are studying how one of its toxins gets into cells.

Read more


Disease-fighting antibody production

Apr. 20, 2018—New research links nutrient-responsive cellular signaling to the antibody-mediated immune response.

Read more


Voluntary exercise and energy balance

Mar. 23, 2018—Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered.

Read more


Kidney disease imaging

Mar. 22, 2018—Making multiple measurements with MRI can provide comprehensive information about the molecular and cellular changes caused by kidney injury.

Read more


Peek named to serve on NIDDK Advisory Council

Mar. 15, 2018—Richard Peek, MD, director of the Vanderbilt Digestive Disease Research Center (VDDRC) and chief of the Division of Gastroenterology, Hepatology and Nutrition, has been appointed to serve on the advisory council of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Read more


A new target for neuroblastoma

Feb. 14, 2018—Vanderbilt investigators have discovered that a sirtuin protein has oncogenic properties in neuroblastoma cells — and that blocking it reduces their growth and tumor-like characteristics.

Read more


Cognition in rare hormonal disorder

Feb. 13, 2018—Vanderbilt investigators have conducted the first systematic evaluation of cognitive function in children with a rare genetic disorder.

Read more


Page 1 of 1412345678...Last »

Upcoming Events

MORE EVENTS »